Prox1 interacts with Atoh1 and Gfi1, and regulates cellular differentiation in the inner ear sensory epithelia  by Kirjavainen, Anna et al.
Developmental Biology 322 (2008) 33–45
Contents lists available at ScienceDirect
Developmental Biology
j ourna l homepage: www.e lsev ie r.com/deve lopmenta lb io logyProx1 interacts with Atoh1 and Gﬁ1, and regulates cellular differentiation in the inner
ear sensory epithelia
Anna Kirjavainen a, Marilin Sulg a, Florian Heyd b, Kari Alitalo c, Seppo Ylä-Herttuala d, Tarik Möröy b,
Tatiana V. Petrova c, Ulla Pirvola a,⁎
a Institute of Biotechnology, University of Helsinki, 00014 Helsinki, Finland
b Institut de Recherches Cliniques de Montréal, Montréal, Quebéc, Canada H2W 1RT
c Molecular/Cancer Biology Laboratory and Ludwig Institute for Cancer Research, Biomedicum Helsinki and Helsinki University Central Hospital, University of Helsinki,
00014 Helsinki, Finland
d Department of Molecular Medicine, A.I.V. Virtanen Institute, University of Kuopio, 70211 Kuopio, Finland⁎ Corresponding author. Fax: +358 9 19159366.
E-mail address: ulla.pirvola@helsinki.ﬁ (U. Pirvola).
0012-1606/$ – see front matter © 2008 Elsevier Inc. Al
doi:10.1016/j.ydbio.2008.07.004a b s t r a c ta r t i c l e i n f oArticle history: Inner ear hair cells and su
Received for publication 13 May 2008
Revised 28 June 2008
Accepted 1 July 2008










Survivalpporting cells arise from common precursors and, in mammals, do not show
phenotypic conversion. Here, we studied the role of the homeodomain transcription factor Prox1 in the
inner ear sensory epithelia. Adenoviral-mediated Prox1 transduction into hair cells in explant cultures
led to strong repression of Atoh1 and Gﬁ1, two transcription factors critical for hair cell differentiation
and survival. Luciferase assays showed that Prox1 can repress transcriptional activity of Gﬁ1 inde-
pendently of Atoh1. Prox1 transduction into cochlear outer hair cells resulted in degeneration of these
cells, consistent with the known phenotype of Gﬁ1-deﬁcient mice. These results together with the
widespread expression of endogenous Prox1 within the population of inner ear supporting cells point to
the role for Prox1 in antagonizing the hair cell phenotype in these non-sensory cells. Further, in vivo
analyses of hair cells from Gﬁ1-deﬁcient mice suggest that the cyclin-dependent kinase inhibitor p57Kip2
mediates the differentiation- and survival-promoting functions of Gﬁ1. These data reveal novel gene
interactions and show that these interactions regulate cellular differentiation within the inner ear
sensory epithelia. The data point to the tight regulation of phenotypic characteristics of hair cells and
supporting cells.
© 2008 Elsevier Inc. All rights reserved.Introduction
Hair cells (HCs) and supporting cells of the inner ear arise from
common progenitors (Fekete et al., 1998) that during embryogenesis
exit the cell cycle and initiate cell type-speciﬁc differentiation, leading
to the formation of the mosaic-like cytoarchitecture typical to the
cochlear (organ of Corti) and vestibular sensory epithelia. Because of
common origin, not only activators, but also repressors of the opposite
phenotype are likely to be involved. The Notch signaling-based
“lateral inhibition” is a key mechanism in cell fate speciﬁcation in
the sensory patches of the early-developing inner ear (Lewis, 1998). As
a result of signaling between Notch receptors and their ligands, and
the induction of the basic helix-loop-helix (bHLH) transcription factor
Atoh1, a subset of precursor cells start to differentiate as HCs, the
primary cell type. Induction of Atoh1 is followed by upregulation of
factors such as Gﬁ1 (for “growth factor independence 1”) and myosin
VIIa, which mark the onset of HC histogenesis (reviewed by Kelley,
2006). Members of Hes (for “hairy and enhancer of split”) and Id (forl rights reserved.“inhibitor of differentiation and/or DNA binding”) families have been
suggested to promote supporting cell development by antagonizing
Atoh1 activity (Zheng et al., 2000; Jones et al., 2006). Signaling
through ﬁbroblast growth factor receptor 3 (Fgfr3) is crucial for the
differentiation of speciﬁc supporting cell types in the organ of Corti
(Colvin et al., 1996).
The mammalian zinc-ﬁnger transcription factor Gﬁ1 is critical for
hematopoiesis and the development of cochlear HCs and pulmonary
neuroendocrine cells (reviewed by Jafar-Nejad and Bellen, 2004;Möröy,
2005; Kazanjian et al., 2006). Gﬁ1 is orthologous toDrosophila Senseless
that is required for the development of the ﬂy's peripheral nervous
system (Nolo et al., 2000). Cellular events regulated by Gﬁ1 and
Senseless include proliferation, cell fate decisions, differentiation and
apoptosis. They can function as DNA-binding transcriptional repressors
(Grimes et al., 1996; Zweidler-McKay et al., 1996). In the case of Gﬁ1, this
negative regulation requires its N-terminal SNAG domain (Grimes et al.,
1996; Fiolka et al., 2006). In addition to target gene repression, Senseless
has been shown to function as a co-activator of bHLH proneural genes
(Acar et al., 2006). In themouse inner ear, Gﬁ1 is expressed indeveloping
cochlear and vestibular HCs from the onset of morphological differ-
entiation onward (Wallis et al., 2003). Gﬁ1 inactivation by homologous
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HC loss. CochlearHCs show initial signsofmorphological differentiation,
but thereafter they rapidly degenerate, so that a large part them are lost
alreadyat birth.Outerhair cells (OHCs) rather than innerhair cells (IHCs)
are the primary targets of Gﬁ1 deﬁciency. Interestingly, vestibular HCs
are largely unaffected by Gﬁ1 loss, although also a part of these mutant
cells show signs of degeneration at adulthood (Wallis et al., 2003;
Hertzano et al., 2004).
The homeodomain gene Prox1 is the vertebrate ortholog of the
Drosophila Prospero, which was originally shown to be critical for the
development of neuronal lineage of the ﬂy (Doe et al., 1991; Manning
andDoe,1999; Li andVaessin, 2000). These studies and thoseperformed
withmice (Wigle and Oliver,1999;Wigle et al., 1999, 2002; Sosa-Pineda
et al., 2000;Honget al., 2002; Petrova et al., 2002; Dyer et al., 2003) have
demonstrated the role of Prospero/Prox1 as a link between terminal
mitoses and the onset of differentiation, and in cell fate decisions of
diverse cell types. Prospero/Prox1 can act as transcriptional repressors or
activators, dependingon the target geneandcellular context (Honget al.,
2002; Petrova et al., 2002; Choksi et al., 2006).
An earlier study showed that Prox1 is expressed in the developing
inner ear sensory epithelia of the mouse (Bermingham-McDonogh et
al., 2006). Prox1 expressionwas shown in precursor cells and, after the
onset of differentiation, in two types of cochlear supporting cells, the
pillar and Deiters cells. In the present study, using a gain-of-function
approach in explants cultures, we present evidence of novel target
genes of Prox1 and show its impact on the HC phenotype and
development. Gﬁ1 is one of the identiﬁed targets of repression by
Prox1. We have used Prox1 overexpression to acutely deplete Gﬁ1
from HCs, and we provide mechanistic insights about the differentia-
tion- and survival-promoting functions of Gﬁ1.
Materials and methods
Mice
The NMRI mouse strain was used for expression studies and
explant cultures. Generation and the genotyping protocol of Gﬁ1:
GFP knock-in mice (Yücel et al., 2004) and Fgfr3 knock-out mice
(Colvin et al., 1996; obtained from Jackson Laboratory) have been
described. For timed pregnancies, the morning of vaginal plug
identiﬁcation was taken as embryonic day 0.5 (E0.5) and the day of
birth as postnatal day 0 (P0). Animal care was in accordance with
institutional guidelines.
Explant cultures and viral infections
Organotypic explant cultures of the cochlear and utricular sensory
epitheliawere established at E15 and P1. Explants weremaintained on
pieces of Nuclepore ﬁlter membrane (Whatman) in F12 medium
containing 10% fetal bovine serum (Hyclone) and penicillin. The
adenoviral constructs AdGFP and AdProx1 were used. The transgenes
were expressed under CMV promoter. Cloning and propagation of
replication-deﬁcient adenoviruses of serotype 2 have been described
previously (Laitinen et al., 1998). Prior to infection, dissected explants
were stabilized on ﬁlters for 4 to 12 h. Infections were done in serum-
free medium at the titers of 3.1×106–107 pfu/ml for AdGFP and
3.3×106–107 pfu/ml for AdProx1. Utricular explants were infected for
6 h, one explant in a volume of 20 μl, and thereafter maintained in
serum-containing medium for 1 to 16 days. Cochlear explants were
infected for 2 to 3 days and thereafter cultured in serum-containing
medium for the same time period.
Explants were ﬁxed in 4% paraformaldehyde (PFA) in PBS for
15 min. Double and triple immunoﬂuorescent staining in PBS
containing 0.25% Triton-X-100 and 10% normal serumwas performed
using the following antibodies: goat polyclonal Prox1 (R & D), guinea
pig polyclonal Gﬁ1 (Wallis et al., 2003), rabbit polyclonal Atoh1 (Helmsand Johnson,1998), rabbit polyclonal myosin VIIa (Hasson et al., 1997),
rabbit polyclonal Id1 (Santa Cruz), mouse monoclonal parvalbumin
(Swant) and goat polyclonal p57Kip2 (Santa Cruz). Secondary anti-
bodies conjugated to Alexa 350, Alexa 488 and Alexa 594 (Invitrogen)
were used for visualization. Mounting was done with Prolong Gold
Antifade Agent (Invitrogen) or Vectashield (Vector Laboratories).
Images were acquired through a CCD camera (DP70, Olympus) on a
microscope (BX61, Olympus) and analySIS software (Olympus), and
processed using Adobe Photoshop 7.0 (Adobe Systems).
For quantiﬁcation of adenoviral transduction efﬁciency in AdGFP-
infected explants, numbers of cells with GFP ﬂuorescence were
counted in the population of myosin VIIa+HCs. For quantiﬁcation of
Gﬁ1 repression in AdProx1- and AdGFP-infected explants, numbers of
Gﬁ1+cells were counted in the population of Prox1+/myosin VIIa+and
GFP+/myosin VIIa+HCs, respectively. Corresponding quantiﬁcationwas
done to determine the extent of Atoh1 repression in cochlear explants.
At least 3 random microscopic ﬁelds were analyzed per explant.
Immunohistochemistry and detection of apoptosis
Whole heads from E13.5, E14.5, E15.0, E15.5 and E16.5 embryos
and dissected inner ears from E17.5 and E18.5 embryos as well as P0
and P1 pups were ﬁxed overnight in 4% PFA, embedded in parafﬁn and
cut to 5-μm-thick sections. Inner ears from P7 and P25 mice were
perilymphatically perfusedwith PFA prior to immersion in the ﬁxative
and thereafter decalciﬁed in 0.5 M EDTA, pH 8.0. Epitopes were
unmasked by microwave heating in 10 mM citrate buffer, pH 6.0, for
10 min. Antibodies used were the same as in wholemount stainings
plus the rabbit polyclonal GFP antibody (Invitrogen). Detection was
done with the Vectastain Elite Kits and DAB Detection Kit (Vector
Laboratories). At least 5 serially sectioned inner ears were analyzed
per age. To detect apoptotic cells, AdProx1- and AdGFP-infected
cochlear explants, in which Prox1/GFP and myosin VIIa were ﬁrst
detected as wholemounts (see above), were embedded in parafﬁn and
sectioned. ApopTag Peroxidase In Situ Apoptosis Detection Kit
(Millipore), containing the sheep polyclonal digoxigenin antibody,
was used according to manufacturer's instructions. Sections were
counterstained with methyl green.
In situ hybridization
In situ hybridization was performed with 35S-labelled riboprobes
on PFA-ﬁxed and parafﬁn-embedded sections as described (Wilkinson
and Green, 1991). At E16.5 and P0, inner ears from wildtype and
Gﬁ1GFP/GFP mice were analyzed for p57Kip2 and p21Cip1expression. At
both stages, six ears of each genotype were studied. In part of the
views (Fig. 6A and Figs. 8F–I, L, M), autoradiographic silver grains in
the dark ﬁeld image were selected, coloured red and superimposed
onto the brightﬁeld image. AdProx1- and AdGFP-infected cochlear
explants, six of each, and inner ears of E15.5 and P0 mice were
prepared for parafﬁn sections and exposed to in situ hybridization
with the Fgfr3 riboprobe. Hematoxylin was used for counterstaining.
Luciferase reporter assay
NIH 3T3 cells were plated at 5 × 105 cells in 12-well plates. After
18 h, cells were transfected using FuGENE HD (Roche). The amount
of DNA was kept constant in each transfection by adjusting the
amount of the empty expression plasmids (pAMC and FLAG). Cells
were lysed 30 h after transfection and luciferase activity was
measured with the Luciferase Dual Reporter Assay System (Promega).
Fireﬂy luciferace activity was normalized to Renilla luciferase levels
using the pRL-TK plasmid (Promega) as an internal control reporter.
The plasmids used have been characterized before: Gﬁ1 promoter-
driven luciferase plasmid and Gﬁ1 expression plasmid (Yücel et al.,
2004) and MycProx1/pAMC expression plasmid (Petrova et al., 2002).
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Prox1 expression in the cochlea
To relate Prox1 expression to the stage of HC development, we ﬁrst
compared its expression with the proneural gene Atoh1, an early HC
marker that drives precursors towards the HC phenotype, and with
Gﬁ1 andmyosin VIIa, both of whichmark differentiated HCs (Figs. 1A–
I). In the presumptive organ of Corti, we did not detect Prox1 protein
or mRNA at E14.5 or earlier stages (data not shown). Prox1 was ﬁrst
detected in the basal coil of the cochlea at E15.0 (Fig. 1A). In this area,
Prox1 was strongly expressed in the future OHCs, Deiters cells andFig. 1. Expression of Prox1, Gﬁ1, Atoh1 and myosin VIIa, and Prox1 and Prox2 in the organ of
OHCs, pillar cells and Deiters cells, and weakly in non-sensory cells on both sides of the future
At E15.5, concomitantly with Gﬁ1 induction in OHCs, Prox1 level is decreased in these cells, a
non-sensory cells. Myosin VIIa expression is still restricted to IHCs. (G–I) At P0, pillar and Deit
stained, similar to Gﬁ1- and Atoh1-positive OHCs. (J, K) Prox1 expression becomes restricted
unaltered in the cochlea of Gﬁ1GFP/GFP mutant mice. (M) At P0, Prox1 expression is unaltered
sensory epithelium. (N–P) Darkﬁeld in situ hybridization views show that, at P0, Prox1 is pre
shown in the nodose ganglion neurons at E13.5. Abbreviations: IHC, inner hair cell; OHCs, ou
Hensen cell; C, Claudius cell; myo, myosin VIIa. Scale bar: 40 μm for panels A–M; 60 μm forpillar cells (Fig. 1A), consistent with an earlier description (Berming-
ham-McDonogh et al., 2006). In addition, not described in the earlier
paper, we found weak expression in other types of non-sensory cells
located on both sides of pillar and Deiters cells (Fig. 1A). At E15.0, cells
positive for Prox1 lacked signs of morphological differentiation, but,
based on Atoh1 expression, a part of them had adopted the HC fate
(Fig. 1C). At this stage, the absence of Gﬁ1 in the area of future OHCs
pointed to undifferentiated status of these cells (Fig. 1B). This is in
contrast to adjacent IHCs that did not express Prox1 at any stage, but
that expressed Gﬁ1 from E14.5 onward (Fig. 1B).
At E15.5, the ﬁrst Gﬁ1-positive OHCs appeared in the basal coil of
the cochlea, close to the lumen (Fig. 1E). At the same stage, OHCsCorti of the cochlea. (A–C) At E15.0, Prox1 is strongly expressed in the region of future
organ of Corti (arrowheads). IHCs (arrow) lack Prox1, but express Gﬁ1 and Atoh1. (D–F)
s opposed to the underlying supporting cells. Prox1 is weakly expressed in surrounding
ers cells show strong Prox1 expressionwhile Hensen and Claudius cells are moreweakly
to outer pillar cells and outer Deiters cells postnatally. (L) At E15.5, Prox1 expression is
in the organ of Corti of Gﬁ1GFP/GFP mutant mice. Arrows mark OHCs in the degenerating
sent in the organ of Corti, as opposed to Prox2. As a positive control, Prox2 expression is
ter hair cells; D, Deiters cell; P, pillar cell, OD, outer Deiters cell; OP, outer pillar cell; H,
panels N–P.
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not yet expressed in OHCs (Fig. 1F), these observations being
consistent with the data that Gﬁ1 is one of the earliest markers of
HCs undergoing morphological differentiation (Wallis et al., 2003). In
contrast to OHCs, strong Prox1 expression was maintained in Deiters
and pillar cells at E15.5 (Fig. 1D). In addition, weak Prox1 expression
persisted in other types of supporting cells, including inner phalangeal
cells located underneath IHCs as well as Hensen and Claudius cells on
the lateral side of the organ of Corti (Fig. 1D).
Prox1 induction followed a base-to-apex gradient along the length
of the cochlear duct. At P0, Deiters and pillar cells showed strong
Prox1 expression (Fig. 1G; Bermingham-McDonogh et al., 2006)
whereas Gﬁ1 (Fig. 1H), Atoh1 (Fig. 1I) and myosin VIIa (data not
shown) were conﬁned to HCs. In contrast to Bermingham-McDonogh
et al. (2006) who showed rapid Prox1 downregulation in OHCs, we
found more progressive downregulation. Prox1 was expressed in
OHCs of the basal coil still at P0 (Fig. 1G) and P1, but not anymore at P7
(Fig. 1J). The weak Prox1 expression found at E15 in non-sensory cells
on both sides of pillar and Deiters cells (Figs. 1A, D) was down-
regulated by P0, except in Hensen and Claudius cells (Fig. 1G).
Interestingly, in the postnatal cochlea, at P7 and P25, Prox1 was still
present in Deiters and pillar cells, most strongly in the outer pillar cells
and lateralmost Deiters cells (Figs. 1J, K).
Taken together, the largely non-overlapping expression pattern of
Prox1 andGﬁ1 in the developing organ of Corti suggested for a possible
inhibitory relationship, in either direction. The fact that Prox1
expression was unaltered in the inner ear sensory epithelia of
homozygous Gﬁ1GFP/GFP mutant mice (Yücel et al., 2004), as analyzed
at E15.5 (Fig. 1L) and P0 (Fig. 1M) suggested that Prox1 is an upstream
regulator in this putative relationship. As opposed to Prox1, the
recently identiﬁed member of the family of Prospero-related homeo-
box genes, Prox2 (Nishijima and Ohtoshi, 2006) was not expressed in
the inner ear sensory epithelia at any stage, as analyzed by in situ
hybridization (Figs.1N, O). The embryonic nodose ganglionwas used asFig. 2. Expression of Prox1, Gﬁ1 and Atoh1 in the utricle. (A, D, G) At E13.5, Prox1 is expressed
Atoh1 expression. (B, E, H) At E15.0, Prox1 expression is conﬁned to supporting cells (arrowh
expression is downregulated in a part of HCs (arrows in panel H). (C, F, I) At P0, Prox1 express
in panel C) and Gﬁ1 throughout the HC population. In contrast, most of HCs lack Atoh1 (arra positive control for Prox2 expression (Fig. 1P; Nishijima and Ohtoshi,
2006).
Prox1 expression in the utricle
We next compared the expression of Prox1 with Atoh1 and Gﬁ1
in the sensory epithelium of utricle, one of the vestibular organs
(Figs. 2A–I). As compared to the organ of Corti of the cochlea where
progenitors terminally mitose between E12 and E14, cells exit the cell
cycle and start to differentiate a few days earlier in the vestibular
sensory epithelia (Ruben, 1967). Prox1 was present in the utricle at
E13.5, at the earliest stage analyzed (Fig. 2A). The expression was
maintained at E15.0 (Fig. 2B) and P1 (Fig. 2C for P0), these data
differing from an earlier study (Bermingham-McDonogh et al., 2006)
in which Prox1 was not detected in the utricle after E16.5. Between
E13.5 and P1, Prox1 was present in supporting cells, while HCs,
identiﬁed by their morphology and location close to the lumen, lacked
expression (Figs. 2A–C). Staining of adjacent sections with antibodies
against Gﬁ1 and Atoh1 conﬁrmed that the HC region lacked Prox1
(Figs. 2D–I). Of note, after the onset of differentiation, utricular HCs
showed rapid Atoh1 downregulation, so that already at E15 a large
part of them were only weakly positive or completely lacked Atoh1.
The decrease in Atoh1 expression progressed further along develop-
ment (Fig. 2I). This is different from Gﬁ1 that was present in HCs
throughout development (Figs. 2D–F). Together, the presence of Prox1
in utricular supporting cells and its largely complementary expression
pattern relative to the HC markers suggest for a role, similar as in the
organ of Corti, as a positive regulator of supporting cell development
and/or as a repressor of the HC phenotype.
Adenoviruses infect hair cells in explant cultures
To be able to overexpress Prox1 in HCs in explant cultures, we
examined the potential of adenoviral transduction into these cells.in supporting cells, this expression being largely complementary to HC-speciﬁc Gﬁ1 and
eads mark supporting cells and arrows HCs in panel B) and Gﬁ1 to HCs. Note that Atoh1
ion is maintained in supporting cells (arrowhead marks supporting cells and arrow HCs
ows in panel I). Scale bar: 40 μm for panels A–I.
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CMV promoter (Laitinen et al., 1998) were used. In utricular explants,
a 6-hour-long infection resulted in efﬁcient transduction into HCs
(Fig. 3). Transgenes were expressed in myosin VIIa+utricular HCs
already after 1 day in vitro (DIV) (data not shown). Expression became
more prominent after 3 DIV (Figs. 3A–D‴) and was maintained
throughout the culture period, up to 16 days (Figs. 3E–F‴; data not
shown). Quantiﬁcation in utricular explants infected with AdGFP at E15
and P1, andmaintained for 3DIV showed that 64% and 39%, respectively,
of HCs were double-labeled for myosin VIIa and GFP (a total of 958 HCs
in six E15 explants and 989 HCs in ﬁve P1 explants counted).Fig. 3. Ectopic Prox1 expression represses Gﬁ1 in HCs, as shown in E15 utricular explants infec
HCs in AdGFP-infected explants. (B, B′) In AdProx-infected explants after 3 DIV, only a part of
affect Gﬁ1 expression in myosin VIIa+HCs. (D–D‴) After 3 DIV, AdProx1-infected, myosin VII
explant. (E–E″′) After 10 DIV, AdGFP-infected, myosin VIIa+HCs express Gﬁ1. (F–F‴) After 10 D
myo, myosin VIIa. Scale bar: 100 μm for panels A, A′, B, B′; 25 μm for panels C–F‴.For successful adenoviral transduction into cochlear HCs, an
infection time longer than in the case of utricular HCs was needed
(seeMaterials andMethods; Figs. 4 and 7). In P1 cochlear cultures, 83%
of OHCs were infected by AdGFP after 4 DIV (totally 465 OHCs in 3
explants counted). Transduction into IHCs was variable between
explants. Similarly, as compared to OHCs, supporting cells of the
inner ear sensory epithelia were more inefﬁciently and variably
transduced by adenoviruses. Together with the fact that no adverse
effects on the morphology and survival of HCs were seen, our data
speak for the usefulness of adenoviruses in gene transfer into both
utricular and cochlear HCs in vitro.tedwith AdProx1 and AdGFP. (A, A′) After 3 DIV, myosin VIIa and Gﬁ1 are coexpressed in
myosin VIIa+HCs express Gﬁ1. (C–C‴) As analyzed after 3 DIV, AdGFP infection does not
a+HCs show Gﬁ1 repression (arrowheads), as opposed to non-infected HCs in the same
IV, Gﬁ1 is repressed in AdProx1-infected, myosin VIIa+HCs (arrowheads). Abbreviations:
Fig. 4. Prox1 overexpression represses Gﬁ1 and Atoh1 in HCs, as shown in AdProx1- and AdGFP-infected cochlear explants. (A–A″) In E15 cochlear explants analyzed after 5 DIV,
AdGFP infection does not affect Gﬁ1 expression in myosin VIIa+HCs. (B–B″) In E15 cochlear explants analyzed after 5 DIV, AdProx1 infection leads to strong Gﬁ1 repression in myosin
VIIa+OHCs. Observe Gﬁ1+OHCs in a non-infected area of the explant. Note also the disintegrity of OHC rows, as seen by myosin VIIa-staining. (C–C″) In P1 cochlear explants analyzed
after 4 DIV, AdGFP infection does not affect Gﬁ1 or myosin VIIa expression in HCs. (D–D″) In P1 cochlear explants analyzed after 4 DIV, AdProx1-infected OHCs show strong Gﬁ1
repressionwhile myosin VIIa is unaltered. Note that, in contrast to the younger explants, OHC rows are intact. (E–E″) In E15 cochlear explants analyzed after 5 DIV, AdGFP infected HCs
show unaltered Atoh1 expression. (F–F″) In E15 cochlear explants analyzed after 5 DIV, AdProx1-infected OHCs show Atoh1 repression. Abbreviations: IHCs, inner hair cells; OHCs,
outer hair cells; myo, myosin VIIA. Scale bar: 40 μm for panels A–F″.
38 A. Kirjavainen et al. / Developmental Biology 322 (2008) 33–45Ectopic Prox1 expression represses Gﬁ1 in utricular hair cells
Utricular explants were infected with AdProx1 at E15 and P1, and
cultured for 3 and 10 days. We ﬁrst focused on myosin VIIa and
found that its expression was unaltered in AdProx1-infected HCs
(Fig. 3). To study the effect of ectopic Prox1 expression on Gﬁ1,
which is normally expressed throughout the HC population (Figs.
2E–G), AdProx1-infected explants were triple-labeled with anti-bodies against Prox1, Gﬁ1 and myosin VIIa. Hair cells with ectopic
Prox1 showed strong repression of Gﬁ1, as opposed to AdGFP-
infected HCs (Figs. 3A–F‴). Quantiﬁcation revealed that in explants
infected with AdProx1 at E15 and maintained for 3 DIV, only 18% of
Prox1+/myosin VIIa+HCs showed Gﬁ1 expression. In AdGFP-infected
explants, this value was 96% for GFP+/myosin VIIa+HCs (Fig. 5A). Gﬁ1
repression was signiﬁcant also in cultures set up at P1, although
the effect was somewhat weaker than in E15 explants (Fig. 5A).
Fig. 5. Prox1 overexpression represses Gﬁ1 and Atoh1. (A) E15 and P1 utricular explants
were infected with AdProx1 and AdGFP, and cultured for 3 or 10 days. Numbers of Gﬁ1+
cells were counted amongst Prox1+/myosin VIIa+and GFP+/myosin VIIa+HCs. Data are
presented as mean±s.d. Numbers of explants analyzed and total numbers of HCs
counted are indicated. Abbreviation: myo, myosin VIIa. (B) Cochlear explants were
infected with AdProx1 and AdGFP, and cultured for 5 days. The percentage of HCs with
Atoh1 expression is shown. (C) Repression of Gﬁ1 promoter activity by Prox1. NIH 3T3
cells were co-transfected with the Gﬁ1-luciferase reporter (1 μg) along with the Prox1
(5, 20, 100 ng) expression plasmid or the corresponding empty pAMC plasmid. For
comparison, negative autoregulation by Gﬁ1 is shown, using the Gﬁ1-luciferase reporter
(500 ng) along with the Gﬁ1 (5, 20 ng) expression plasmid or the empty FLAG plasmid.
The relative luciferase activity is the ﬁreﬂy luciferase activity normalized to that of
renilla luciferase. This activity (mean±s.d) is presented as percentage of empty control
from 4 independent experiments, each in triplicate.
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Prox1.
Prox1 overexpression represses Gﬁ1 and Atoh1 in cochlear hair cells
In AdProx1-infected cochlear explants, endogenous Prox1 was
expressed in supporting cells located underneath the lumenal HCexpression of the Prox1 transgene in HCs was clearly stronger than its
endogenous expression (Fig. 4). In cochlear cultures initiated at E15
and P1, andmaintained for 5 and 4 DIV, respectively, AdProx1-infected
HCs showed efﬁcient repression of Gﬁ1, while myosin VIIa expression
was unaffected (Figs. 4A–D″). Gﬁ1 was repressed both in OHCs and
IHCs, but the effect was more pronounced in OHCs (Figs. 4A–D″).
Quantiﬁcation in cochlear cultures initiated at P1 revealed that only
2% of Prox1+/myosin VIIa+OHCs were immunoreactive for Gﬁ1, while
this value was 100% for GFP+/myosin VIIa+OHCs in AdGFP-infected
cultures (Fig. 5A).
Atoh1 has been suggested to positively regulate Gﬁ1 expression in
the inner ear HCs and the intestinal epithelium (Wallis et al., 2003;
Shroyer et al., 2005). Therefore, the observed Gﬁ1 repression
following AdProx1 transduction might be an indirect effect, a
consequence of interaction between Prox1 and Atoh1. This could not
be studied in utricular HCs, because these cells showed rapid
downregulation of Atoh1 during embryogenesis, in contrast to
cochlear HCs where Atoh1 expression was maintained until neonatal
stages (Figs. 1 and 2). AdProx1-infected cochlear explants dissected at
E15 and maintained for 5 DIV showed strong Atoh1 repression in HCs,
in contrast to HCs in AdGFP-infected explants (Figs. 4E–F″). Quanti-
ﬁcation showed that only 2% of Prox1+OHCs were immunoreactive for
Atoh1, while this value was 100% for GFP+OHCs in AdGFP-infected
cultures (Fig. 5B). Thus, Prox1 overexpression leads to Atoh1
repression that is similar magnitude to Gﬁ1 repression (Fig. 5A).
Prox1 regulates Gﬁ1 promoter activity
We next studied whether Prox1 can regulate transcription of Gﬁ1
independently of Atoh1. Luciferase assays were done with NIH 3T3
cells. As assessed after 36 h in vitro and using Atoh1 transfected 3T3
cells as positive controls, Atoh1 was not expressed in these cells (data
not shown). We used a previously characterized, 600-bp-long Gﬁ1
promoter fragment that was appended to luciferase reporter cDNA
(Yücel et al., 2004). An autoregulatory mechanism has earlier been
shown at the Gﬁ1 locus, as evidenced by strong repression of Gﬁ1
reporter activity by co-transfection with the Gﬁ1 expression plasmid
(Yücel et al., 2004). This was also seen in our assays (Fig. 5C). The
results showed that Prox1 expression plasmid represses transcrip-
tional activity of Gﬁ1 promoter in a dose-dependent manner (Fig. 5C),
implying that Prox1 and Gﬁ1 can interact, at least in part,
independently of Atoh1.
Prox1 overexpression does not activate Fgfr3 and Id1 in hair cells
Ectopic Prox1 expression activates Fgfr3 transcription in blood
vascular endothelial cells (BECs) (Shin et al., 2006). In agreement with
earlier data (Peters et al., 1993; Pirvola et al., 1995; Bermingham-
McDonogh et al., 2001), Fgfr3 was strongly expressed in cochlear
OHCs and underlying supporting cells at E15.5, at the onset of
morphological differentiation (Fig. 6A). During later stages of devel-
opment, strong Fgfr3 expression was maintained in supporting cells,
while it was downregulated in OHCs (data not shown; Pirvola et al.,
1995; Bermingham-McDonogh et al., 2001). This spatiotemporal
expression pattern corresponds to Prox1 expression (compare
Fig. 6A and Fig. 1D), suggesting for a possible interaction between
these factors. We ﬁrst analyzed Prox1 expression in the organ of Corti
of Fgfr3 knock-out mice at E15.5 and P0. It was comparable to the
expression seen in wildtype animals (compare Fig. 6B and Fig. 1D). To
study whether Prox1 overexpression can activate Fgfr3 in OHCs,
AdProx1- and AdGFP-infected cochlear explants (P1) were cultured for
4 days, and thereafter parafﬁn sections were prepared and exposed to
in situ hybridization with the Fgfr3 probe. Adjacent sections were
immunostained with Prox1 or GFP antibodies to reveal infected areas
of cochlear explants. In these areas, HCs did not show Fgfr3
upregulation (Figs. 6C–F). Together, these data argue against a close
Fig. 6. Fgfr3 and Id1 expression in the inner ear explants infected with AdProx1 and AdGFP. Prox1 expression in the cochlea of Fgfr3 null mutant mice. (A) A section through the inner
ear from a wildtype mouse at E15.5 shows Fgfr3 expression in OHCs and underlying supporting cells. (B) A section through the inner ear from an Fgfr3 null mutant mouse at E15.5
shows unaltered Prox1 expression in OHCs and supporting cells (compare to Fig. 1D). (C) A cochlear explant (P1) was infected with AdProx1 and maintained for 4 DIV. It was
processed for parafﬁn sections. Infected cells are revealed by Prox1 immunostaining. Note that endogenous Prox1 expression in supporting cells (arrowheads) is weaker than ectopic
expression in HCs (arrows). (D) In an adjacent section exposed to in situ hybridization, strong Fgfr3 expression is seen in supporting cells, but not in HCs. (E) A corresponding section
through an AdGFP-infected cochlear explant shows GFP-immunoreactive HCs. (F) In an adjacent section, Fgfr3 is prominently expressed in supporting cells, but not in HCs. (G, H) As
seen in sections through the inner ear at E15.0 and P0, Id1 is expressed in supporting cells, but not in HCs. (I, I′) In AdProx1-infected utricular explants (E15) maintained for 10 DIV, Id1
expression is conﬁned to supporting cells, as evidenced in a wholemount specimen by its non-overlapping expression with parvalbumin (I). Id1 is not upregulated in AdProx1-
infected HCs (I′). Abbreviations: co, cochlea; ut, utricle; HCs, hair cells; SCs, supporting cells; IHC, inner hair cell; OHCs, outer hair cells; pa, parvalbumin. Scale bar: 60 μm for panel A;
50 μm for panles B–F; 40 μm for panels G,H; 30 μm for panels I, I′.
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direction.
Ectopic Prox1 expression activates Id2 in differentiated BECs
(Petrova et al., 2002). Transcripts of several members of the Id family
have been localized to cochlear supporting cells and Ids have been
suggested to antagonize Atoh1 expression (Jones et al., 2006). These
data prompted us to determine whether Prox1 overexpression can
activate Ids in HCs. Of the four members of the Id family, we focused
on Id1, which negatively regulates transcription of bHLH genes in cells
such as neuronal precursors (Lyden et al., 1999; Jögi et al., 2002).
Consistent with earlier data at the mRNA level (Jones et al., 2006),
sections through the inner ear at E15.0 and P0 showed the presence of
Id1 protein in cochlear supporting cells (data not shown). In addition,at these stages, we localized Id1 to vestibular supporting cells (Figs.
6G, H). Utricular explants were infected with AdProx1 at E15 and
maintained for 10 DIV. Triple-labeling with antibodies against Prox1,
Id1 and the hair-cell-marker parvalbumin failed to show Id1
expression in infected utricular HCs (Figs. 6I, I′). Thus, ectopic Prox1
expression does not upregulate Id1 in this cellular context.
Functional consequences of Prox1 overexpression
We next determined whether Prox1 overexpression has functional
consequences on the differentiated HC phenotype. AdProx1 infection
did not affect HC survival in utricular explants, even after long-term
culture period, up to 16 DIV (Fig. 3; data not shown). In contrast, in
Fig. 7. Degeneration of OHCs in E15 cochlear explants infected with AdProx1. (A) An AdProx1-infected explant shows efﬁcient transduction in the organ of Corti. Boxed areas
represent the high magniﬁcation views seen in panels B–D″. (B–D″) AdProx1 infection leads to OHC degeneration that follows a base-to-apex gradient, as shown in views taken from
different levels of the cochlear duct. The specimen is double-labeled for Prox1 and myosin VIIa. (E, F) In contrast to AdGFP-infected explants, OHCs degenerate through apoptosis in
AdProx1-infected explants. (F) is a section from the cochlea shown in panel A, speciﬁcally from the level shown in panels D–DW. (G–H″) In contrast to AdGFP-infected explants, OHC
degeneration is associated with Gﬁ1 repression in AdProx1-infected explants, as shown by triple-labeling for Prox1, Gﬁ1 andmyosin VIIa. Abbreviations: IHCs, inner hair cells; OHCs,
outer hair cells; myo; myosin VIIa; F, ﬁlter. Scale bar: 200 μm for panel A; 40 μm for panels B–D″; 60 μm for panels E, F; 30 μm for panels G–H″.
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and maintained for 5 DIV, dProx1 transduction resulted in OHC
degeneration (Figs. 7A–H″). This degeneration had a distinct spatial
pattern along the length of the cochlear duct, so that the basal part
showed extensive OHC loss, whilemost of OHCswere still present in the
apical part, albeit often showing signsof degeneration (Figs. 7A–D″). This
degeneration pattern parallels the base-to-apex differentiation gra-
dient. As shown in sections cut through AdProx1-infected cochlear
explants, the presence of DNA fragmentation indicated that OHCs
were lost through apoptosis (Figs. 7E, F). Interestingly, in the same
explants, most of IHCs were intact despite AdProx1 infection (Figs. 7B–
C″, H–H″). Explants transduced with AdGFP did not show HC
degeneration (Figs. 7G–G″). Notably, in contrast to cochlear cultures
set up at E15, those started at P1 and cultured for 4 days showed onlyFig. 8. Expression of p57Kip2, and p57Kip2 and p21Cip1 in the inner ear sensory epithelia of wild
in situ hybridization (F–I, L, M). (A, B, B′) In cochlear wholemounts fromwildtypemice at E17.5
is double-labeled with myosin VIIa, which marks the rows of IHCs and OHCs. (C) As shown by
wholemounts from Gﬁ1GFP/GFPmutant mice at E17.5 show that HCs with GFP ﬂuorescence are
from the mutant mice at P0 show prominent degeneration and loss of HCs, as revealed by G
show that p57Kip2 is expressed in OHCs fromwildtype mice, but is absent from these cells fro
both genotypes show comparable p57Kip2 expression in the inner sulcus. (H, I) Both inwildty
cochlea. (J, K) In the utricle fromwildtype mice, the majority of HCs lack p57Kip2 expression
expression pattern is seen in mutant animals. (L, M) In the utricle from wildtype mice, mo
(arrowhead). Comparable expression pattern is seen in the mutant animals. Abbreviations:
stria vascularis; RM, Reissner's membrane; SCs, supporting cells. Scale bar: 60 μm for panellow numbers of lost OHCs (Figs. 4C–D″). These results demonstrate that
OHC apoptosis following Prox1 overexpression is tightly linked to
developmental stage.
Gﬁ1 regulates p57Kip2 expression in cochlear outer hair cells
We interpret that the speciﬁc degeneration of OHCs following
AdProx1 transduction is linked with Gﬁ1 repression, based on the
phenotype of Gﬁ1 knock-out mice (Wallis et al., 2003). In these
mutants, OHCs degenerate rapidly after they have started to
differentiate, while IHCs degenerate not before later postnatal stages.
Even more strikingly, adult vestibular HCs are largely intact in these
mutant animals (Wallis et al., 2003). These data prompted us to search
for mechanisms underlying the opposite responses of different typestype and Gﬁ1GFP/GFP mutant mice, as revealed by immunohistochemistry (A–E′, J, K) and
and P0, p57Kip2 is expressed in OHCs and veryweakly in a part of IHCs. The P0 specimen
GFP ﬂuorescence at E17.5, the 4 rows of HCs are intact in Gﬁ1GFP/+mice. (D, D′) Cochlear
present, but they are not intact and do not express p57Kip2. (E, E′) Cochlear wholemounts
FP ﬂuorescence. p57Kip2 is not expressed in HCs. (F, G) Sections through cochleas at P0
m Gﬁ1GFP/GFP mutant mice. Both views are from the upper part of the cochlea. Note that
pe and mutant mice, p21Cip1 is expressed in HCs, as well as in non-sensory regions of the
(arrows). However, a part of HCs show this immunoreactivity (arrowhead). Comparable
st of HCs are devoid of p57Kip2 (arrows). However, a part of HCs show this expression
co, cochlea; ut, utricle; IHCs, inner hair cells; OHCs, outer hair cells; IS, inner sulcus; SV,
s A–I, L, M; 60 μm for panels B, D, J; 40 μm for panels J, K.
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et al., 2007), the cyclin-dependent kinase inhibitor (CKI) p57Kip2 was
expressed in OHCs, as demonstrated in cochlear wholemounts by
p57Kip2 staining at E17.5 (Fig. 8A) and by double-staining for p57Kip2
and myosin VIIa at P0 (Figs. 8B, B′). p57Kip2 expression was initiated
between E15.5 and E16.5, and it followed a base-to apex gradient
along the length of the cochlear duct (data not shown). In contrast to
OHCs, only a small number of IHCs showed the presence of p57Kip2
and this expression was very weak (Figs. 8A, B).
Available data on other cell types show that, in addition to a role as a
negative cell cycle regulator, p57Kip2 can control differentiation,
maturation and apoptosis (Yan et al., 1997; Zhang et al., 1997; Dyer
and Cepko, 2000; Joseph et al., 2003). Based on this knowledge and on
the results on p57Kip2 expression in the cochlea (Figs. 8A, B; Laine et al.,
2007), we next studied whether the death-prone phenotype of Gﬁ1-
deﬁcient cochlear OHCs is associated with altered p57Kip2 expression.
We found that p57Kip2 expression was downregulated in HCs of
AdProx1-infected cochlear explants as compared to control specimens
(data not shown). To be able to more deeply penetrate into the
interaction between Gﬁ1 and p57Kip2, we analyzed Gﬁ1GFP/GFP knock-in
mice inwhich the coding region ofGﬁ1 is replaced byGFP cDNA (Yücel et
al., 2004). We ﬁrst conﬁrmed that these homozygotes show a similar
inner ear phenotype as earlier reported for the Gﬁ1 knock-out mice
(Wallis et al., 2003; Hertzano et al., 2004). We found that HC
degeneration progressed in a base-to-apex gradient through the
cochlear duct. The rapid progression of OHC death was striking. As
shown by GFP ﬂuorescence, OHCs were present in Gﬁ1GFP/GFP mutant
mice at E17.5, but they showed abnormal morphology and were not
arranged as three distinct rows (Figs. 8C, D). Most of OHCswere severely
pathological or were lost at P0 (Fig. 8E). We studied the possibility that
Gﬁ1-deﬁcient OHCs re-enter the cell cycle prior to their death. We did
not ﬁnd evidence for this possibility, based on the lack of staining with
the antibodyagainst Ki-67, a proliferationmarker, in the organof Corti of
the mutant mice between E17.5 and P1 (data not shown).
Analysis of cochlear wholemounts at E16.5, E17.5 and P0 revealed
that, in contrast to wildtype mice, p57Kip2 expression was absent in
OHCs from Gﬁ1GFP/GFP mutant mice (Figs. 8DV, EV). This was also seen at
the mRNA level in sections through inner ears from E16.5 and P0 (Figs.
8F, G) animals that were exposed to in situ hybridization. Of note, at
P0, the lack of p57Kip2 was evident in OHCs throughout the cochlear
duct, including its upper part where OHCs appeared still normal (Fig.
8G). In contrast to p57Kip2, expression of p21Cip1, another member of
the Cip/Kip family of CKIs that has been shown to be expressed in the
inner ear HCs (Mantela et al., 2005), was unaltered in the mutants
(Figs. 8H, I). As earlier described (Nagahama et al., 2001; Westbury et
al., 2001), p57Kip2 was strongly expressed in the inner sulcus, a non-
sensory region of the cochlea (Fig. 8F). This expressionwasmaintained
in Gﬁ1GFP/GFP mutant animals (Fig. 8G), consistent with the fact that
Gﬁ1 is not expressed in this region (data not shown).
In contrast to cochlear OHCs, most of utricular HCs were devoid of
p57Kip2 protein and mRNA, as seen during late-embryogenesis and
around birth in parafﬁn sections exposed to immunostaining or
radioactive in situ hybridization (Figs. 8J–M). Interestingly, a small
number of utricular HCs showed the presence of p57Kip2 (Figs. 8J, L)
and this expression was maintained in the Gﬁ1GFP/GFP mutant animals
(Figs. 8K, M). Together, these data suggest that Gﬁ1/p57Kip2 interaction
does not have a pivotal role in the regulation of survival of vestibular
HCs, in contrast to cochlear OHCs.
Discussion
In the current study, we have used adenoviral-mediated over-
expression approach in organotypic cultures of the inner ear sensory
epithelia to study gene interactions that regulate the development of
HCs and supporting cells. These cell types are derived from common
precursors and they do not show phenotypic conversion in mammals.We report the identiﬁcation of Prox1 as a repressor of Atoh1 and Gﬁ1,
two transcription factors critical for HC differentiation, and suggest
that Prox1 antagonizes the differentiated HC phenotype. This
antagonism is likely to have physiological relevance in supporting
cells where endogenous Prox1 is expressed (present study; Berming-
ham-McDonogh et al., 2006). We show that in response to Prox1
overexpression, a speciﬁc HC population, the cochlear OHCs, degen-
erate due the dependence of these cells on Gﬁ1 for survival. Further,
we present evidence of a novel interaction between Gﬁ1 and p57Kip2,
suggesting that this cell cycle regulator mediates the differentiation-
and survival-promoting functions of Gﬁ1. These data provide key
insights about transcriptional regulation of cellular differentiation
within the inner ear sensory epithelia.
Prox1 target genes in the inner ear sensory epithelia
The rapid and strong downregulation of both Atoh1 and Gﬁ1 in the
inner ear HCs with Prox1 overexpression suggests for a close
relationship between these factors. Because Atoh1 positively regulates
Gﬁ1 (Wallis et al., 2003; Shroyer et al., 2005), Prox1's repressive action
on Gﬁ1 is likely to be partially indirect. This is supported by the results
that Gﬁ1 repression was more extensive amongst AdProx1-infected
cochlear HC as compared to AdProx1-infected utricular HCs. Normally,
all cochlear HCs express both Gﬁ1 and Atoh1 whereas all utricular HCs
show the presence of Gﬁ1, but only a part of them express Atoh1.
However, results from our luciferase assays using NIH 3T3 ﬁbroblasts
suggest that Prox1 can repress transcriptional activity of Gﬁ1 reporter.
Thus, Prox1 and Gﬁ1 can interact, in part, independently of Atoh1.
Concerning Atoh1 repression, a possibility was that this effect is
due to Prox1 overexpression-induced activation of Ids, the negative
regulators of bHLH genes. This possibility was relevant, since Prox1
has been shown to activate Ids in another cellular context (Petrova et
al., 2002). However, our results in the inner ear HCs argue against
regulation of Id1 expression by Prox1 and, thus, point to a more direct
interaction between Prox1 and Atoh1 in this context.
It has been recently shown that Senseless and Prospero, the Dro-
sophila orthologs of Gﬁ1 and Prox1, interact in the ﬂy eye. It was
shown that Prospero is a target, most likely indirect one, of repression
by Senseless (Xie et al., 2007). However, our results show unaltered
Prox1 expression in the inner ear sensory epithelia of Gﬁ1GFP/GFP
mutant mice. Particularly, Prox1 was not upregulated in their cochlear
or vestibular HCs. Thus, present results suggest that, in the inner ear
sensory epithelia of the mouse, this interaction is primarily through
Prox1′s repressive action on Gﬁ1.
Prox1 regulates cellular differentiation in the inner ear sensory epithelia
In the organ of Corti of the cochlea where cellular development is
better uncovered relative to the vestibular sensory epithelia (reviewed
byKelley, 2006), Prox1expressionwas initiated inprecursor cells shortly
before they showed signs of morphological differentiation as OHCs or
supporting cells. Thereafter, Prox1 expression gradually disappeared
from OHCs, but was maintained in supporting cells during maturation.
Based on the late timing of Prox1 induction (present study; Berming-
ham-McDonogh et al., 2006) relative to cell cycle exit (Ruben, 1967;
Chen and Segil, 1999; Lee et al., 2006) and on the fact that these events
have opposite gradients along the length of the cochlear duct, Prox1
appears not to regulate terminal mitoses of precursors, a role that has
been suggested for Prospero in the Drosophila nervous system (Li and
Vaessin, 2000). The late timing of Prox1 induction also argues against a
role in the cell type speciﬁcation and commitment processes in the
prosensory epithelia. The base-to-apex gradient of the onset of Prox1
expression parallels the well-known differentiation gradient. Thus,
these correlative data suggest for a role of Prox1 during cellular
differentiation in the inner ear sensory epithelia. The primary site of
action of Prox1 appears to be supporting cells, both of the cochlea and
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population. These data together with the current results that Atoh1 and
Gﬁ1 are repressed in HCs with Prox1 overexpression suggest that this
transcription factor antagonizes the differentiated HC phenotype in
inner ear supporting cells.
In addition to serving as transcriptional repressors, Prox1 (Hong et
al., 2002; Petrova et al., 2002) and Prospero (Choksi et al., 2006) can
activate target genes. Thus, Prox1 may activate transcription of genes
that promote differentiation of inner ear supporting cells, in addition to
its role in antagonizing the HC phenotype. As demonstrated in
endothelial cells, Prox1 can activate Fgfr3 (Shin et al., 2006). Interest-
ingly, Prox1 and Fgfr3 are expressed in cochlear supporting cells, and
Fgf-Fgfr3 signalinghas beensuggested topromotedevelopmentof these
cells (present data; Peters et al., 1993; Pirvola et al., 1995; Colvin et al.,
1996; Bermingham-McDonogh et al., 2001, 2006; Mueller et al., 2002).
However, Fgfr3 was not activated in cochlear HCs that overexpressed
Prox1, demonstrating that ectopic Prox1 is insufﬁcient to reprogram
cochlear HCs towards a supporting cell phenotype that is characterized
by high-level expression of Fgfr3, a known Prox1 target gene.
Acute Gﬁ1 repression leads to outer hair cell degeneration
Ectopic Prox1 expression led to cochlear OHC degeneration. We
interpret that the immediate cause of this degeneration is Gﬁ1
repression, based on the corresponding phenotype of AdProx1-
infected cochlear explants and cochleas of Gﬁ1 null mutant mice
(Wallis et al., 2003). The acuteGﬁ1 repressionperformed in the present
study gives mechanistic insights into Gﬁ1′s function. The results show
that Gﬁ1 repression is devastating for OHCs during the late-embryonic
differentiation period, while OHCs undergoing maturation after birth
aremore resistant to Gﬁ1 depletion. Also the distinct spatial pattern of
OHC degeneration in AdProx1-infected cochlear explants during late-
embryogenesis, the more differentiated OHCs in the basal part being
lost at the stage when less differentiated OHCs in the upper part were
still present but showed signs of degeneration, suggests that Gﬁ1 is
critical for the differentiation and survival of these cells during a
limited time frame of the developmental program.
In the organ of Corti, Prox1 was strongly expressed in two types of
supporting cells, the Deiters and pillar cells. Interestingly, Prox1 was
also weakly expressed in OHCs during late-embryogenesis (Fig. 1).
This expression disappeared after birth. Taking into account that
Prox1 overexpression resulted in Gﬁ1 repression and OHC degenera-
tion, the weak Prox1 expression in normal, Gﬁ1-expressing OHCs is
interesting. The data suggest that high Prox1 levels, as seen in Deiters
and pillar cells, are required for efﬁcient repression of factors that
promote the HC phenotype. This can also be concluded from our
luciferase assays, showing that Prox1 represses transcriptional activity
of the Gﬁ1 promoter in a dose-dependent fashion. These considera-
tions raise the question of the role of endogenous Prox1 in late-
embryonic OHCs. In contrast to OHCs, IHCs did not show Prox1
expression at any stage (present data; Bermingham-McDonogh et al.,
2006). IHCs differentiate before OHCs, as evidenced by earlier
induction of Atoh1, Gﬁ1 and myosin VIIa in these cells (Fig. 1). Thus,
Prox1 appears to act as a brake of OHC differentiation relative to the
timing of differentiation of IHCs. This difference between the two
types of cochlear HCs in temporal development may be important for
the generation of proper cytoarchitecture of the organ of Corti and for
processes such as the establishment of neuronal innervation into HCs.
Gﬁ1/p57Kip2 interaction in hair cells
A striking consequence of AdProx1 infection and the ensuing Gﬁ1
repression was cochlear OHC degeneration, while most of cochlear
IHCs and utricular HCs were unaffected. These results are consistent
with the phenotype of Gﬁ1 null mutant mice (Wallis et al., 2003).
What might be the mechanisms by which Gﬁ1 promotes OHC survivaland that do not to operate in other types of inner ear HCs? We found
that p57Kip2 expression, which is normally seen in developing OHCs,
was abolished from OHCs of Gﬁ1GFP/GFP mutant mice. These results
suggest that Gﬁ1 positively regulates of p57Kip2 expression in OHCs.
This interaction appears not to be present in vestibular HCs, based on
the lack of p57Kip2 in most of utricular HCs of both normal and mutant
animals. However, a small number of utricular HCs showed p57Kip2
expression, but it was unaltered in Gﬁ1GFP/GFPmutant mice. These data
speak for a very speciﬁc dependence of Gﬁ1/p57Kip2 interaction on
cellular context and suggest for the involvement of additional factors
in this interaction. In this respect, it is interesting that OHCs from
Gﬁ1GFP/GFP mutant mice showed unaltered expression of p21Cip1,
another CKI that is present in HCs and that has been shown to be
regulated by Gﬁ1 in other cell types (Karsunky et al., 2002; Duan and
Horwitz, 2003; Hock et al., 2004; Zeng et al., 2004; Duan et al., 2005).
Based on the general view that mammalian Gﬁ1 represses target gene
transcription (Grimes et al., 1996; Zweidler-McKay et al., 1996), its role
in cochlear OHCs as an activator of p57Kip2 appears to be indirect.
However, a few studies have proposed that Gﬁ1 and its close homolog
Gﬁ1b can function as direct transcriptional activators (Sharina et al.,
2000; Osawa et al., 2002), and, thus, a possibility of a direct interaction
between Gﬁ1 and p57Kip2 in OHCs cannot be excluded.
As a CKI, p57Kip2 can associate with and inhibit catalytic activity of
cyclin–cyclin dependent kinase complexes, and thereby regulate cell
cycle exit and the maintenance of the postmitotic state (reviewed by
Cunningham and Rousssel, 2001). In the cochlea, the late timing of
p57Kip2 induction, concomitantly with the onset of Gﬁ1 expression,
makes it unlikely that this CKI regulates cell cycle exit of progenitors.
p57Kip2 may control the maintenance of the postmitotic state of
differentiated HCs, but this role is likely to be a collaborative one
together with other CKIs present in HCs (present data; Chen et al.,
2003; Mantela et al., 2005; Laine et al., 2007). Consistent with this
suggestion, Gﬁ1-deﬁcient cochlear OHCs, lacking p57Kip2 in contrast to
their normal counterparts, failed to show cell cycle reactivation prior
to their death. Importantly, in addition to a role as a cell cycle
regulator, other roles have been suggested for p57Kip2. It has been
shown to control cellular differentiation, maturation and apoptosis,
and these cell cycle-independent functions seem to depend on its
non-CKI regions (Yan et al., 1997; Zhang et al., 1997; Dyer and Cepko,
2000; Joseph et al., 2003). Our data suggest that Gﬁ1/p57Kip2
interaction promotes differentiation and survival of cochlear OHCs,
in contrast to other types of inner ear HCs. Thus, these results seem to
explain, in part, the death-prone phenotype of cochlear OHCs versus
death-resistance of utricular HCs following Prox1 overexpression.
In conclusion
Molecular discrimination of inner ear sensory epithelial cells
underlies the development of therapeutic strategies to treat hearing
and balance disorders. Our data on Atoh1 and Gﬁ1 repression and on
cochlear OHC degeneration in response to Prox1 overexpression show
that transcriptional reprogrammingwith functional consequences can
be achieved in differentiated HCs. Atoh1 gene transfer into inner ear
non-sensory cells has been shown to induce conversion of these cells
to HCs, both in vitro (Zheng and Gao, 2000) and in vivo (Izumikawa et
al., 2005). However, despite myosin VIIa induction, many of the newly
propagated cells retained morphological characteristics of supporting
cells (Izumikawa et al., 2005). Based on the data from the current
study that Prox1 antagonizes the differentiated HC phenotype
through repression of Atoh1 and Gﬁ1, a more complete phenotypic
conversionmight be achieved through Prox1 inhibition in conjunction
with Atoh1 upregulation. In the current study, we have identiﬁed
three novel gene interactions, showing that Prox1 is a repressor of
Atoh1 and Gﬁ1, and that Gﬁ1 targets p57Kip2. In addition to the inner
ear, these interactions are likely to have functional relevance in other
developing tissues and in diseases.
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